|

KQB198 Clinical Trials

2 actively recruiting trials across 2 locations

Pipeline

Phase 1: 2

Top Sponsors

  • Kumquat Biosciences Inc.2

Indications

  • Cancer2
  • Adult1
  • Hematologic Malignancies1
  • Solid Tumor, Adult1

San Francisco, California1 trial

A Study to Investigate the Safety and Efficacy of KQB198 as Monotherapy and in Combination in Participants With Advanced Hematologic Malignancies

University of California, San Francisco (UCSF)

Phase 1

Denver, Colorado1 trial

A Study to Investigate the Safety and Efficacy of KQB198 as Monotherapy and in Combination in Participants With Advanced Solid Malignancies

Sarah Cannon Research Institute at HealthONE

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.